Literature DB >> 31277891

Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.

Rachel P Winograd1, Claire A Wood2, Erin J Stringfellow2, Ned Presnall3, Alex Duello2, Phil Horn2, Tim Rudder4.   

Abstract

BACKGROUND: Leaders of Missouri's State Targeted Response to the opioid crisis (STR) grant have prioritized increasing access to treatment medications for opioid use disorder (MOUD) through a "Medication First" approach. This conceptual framework prioritizes rapid, sustained, low-barrier access to MOUD for optimal impact on decreased illicit drug use and mortality. Medication First principles and practices were facilitated through state-level structural changes and disseminated to participating community treatment programs via a multi-pronged, multi-disciplinary approach. In the first nine months of STR, 14 state-contracted treatment agencies operating 38 sites used STR funding to implement the Medication First model.
METHODS: We utilized state billing and service data to make comparisons before and during STR on the following outcomes: MOUD utilization, timely access to MOUD, amount of psychosocial services delivered, treatment retention at 1, 3, and 6 months, and monthly price of treatment. We conducted follow-up analyses examining differences across MOUD types (no medication, methadone, buprenorphine, oral naltrexone, mixed antagonist + agonist, and extended release naltrexone).
RESULTS: During STR, MOUD utilization increased (44.8% to 85.3%), timeliness of MOUD receipt improved (Median of 8 days vs. 0 days), there were fewer psychosocial services delivered, treatment retention improved at one, three, and six month timeframes, and the median cost per month was 21% lower than in the year prior to STR. All differences were driven by increased utilization of buprenorphine.
CONCLUSIONS: Findings suggest Medication First implementation through STR was successful in all targeted domains. Though much more work is needed to further reduce logistical, financial, and cultural barriers to improved access to maintenance MOUD, the steps taken through Missouri's STR grant show significant promise at making swift and drastic transformations to a system of care in response to a growing public health emergency.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buprenorphine; Opioid use disorder; State targeted response; Substance use treatment

Mesh:

Substances:

Year:  2019        PMID: 31277891     DOI: 10.1016/j.jsat.2019.06.015

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  11 in total

1.  Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.

Authors:  Andrea K Finlay; Erica Morse; Matthew Stimmel; Emmeline Taylor; Christine Timko; Alex H S Harris; David Smelson; Mengfei Yu; Jessica Blue-Howells; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2020-06-24       Impact factor: 5.128

2.  The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.

Authors:  Caleb J Banta-Green; Mandy D Owens; Jason R Williams; Jeanne M Sears; Anthony S Floyd; Wendy Williams-Gilbert; Susan Kingston
Journal:  Addict Sci Clin Pract       Date:  2022-07-07

3.  Introduction to the special issue on innovative interventions and approaches to expand medication assisted treatment: Seizing research opportunities made available by the opioid STR program.

Authors:  Dennis P Watson; Barbara Andraka-Christou; Thomas Clarke; Julie Wiegandt
Journal:  J Subst Abuse Treat       Date:  2019-10-23

4.  A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs.

Authors:  Kathryn Hawk; Lauretta E Grau; David A Fiellin; Marek Chawarski; Patrick G O'Connor; Nikolas Cirillo; Chris Breen; Gail D'Onofrio
Journal:  Acad Emerg Med       Date:  2021-02-28       Impact factor: 3.451

5.  A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.

Authors:  Emmeline N Taylor; Christine Timko; Ingrid A Binswanger; Alex H S Harris; Matthew Stimmel; David Smelson; Andrea K Finlay
Journal:  Subst Abus       Date:  2021-09-29       Impact factor: 3.984

Review 6.  Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit.

Authors:  Yoram Vodovotz; Neal Barnard; Frank B Hu; John Jakicic; Liana Lianov; David Loveland; Daniel Buysse; Eva Szigethy; Toren Finkel; Gwendolyn Sowa; Paul Verschure; Kim Williams; Eduardo Sanchez; Wayne Dysinger; Victoria Maizes; Caesar Junker; Edward Phillips; David Katz; Stacey Drant; Richard J Jackson; Leonardo Trasande; Steven Woolf; Marcel Salive; Jeannette South-Paul; Sarah L States; Loren Roth; Gary Fraser; Ron Stout; Michael D Parkinson
Journal:  Front Med (Lausanne)       Date:  2020-12-22

7.  Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.

Authors:  Dennis P Watson; James A Swartz; Lisa Robison-Taylor; Mary Ellen Mackesy-Amiti; Kim Erwin; Nicole Gastala; Antonio D Jimenez; Monte D Staton; Sarah Messmer
Journal:  BMC Public Health       Date:  2021-03-31       Impact factor: 3.295

8.  Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.

Authors:  Dennis P Watson; Tess Weathers; Alan McGuire; Alex Cohen; Philip Huynh; Clay Bowes; Daniel O'Donnell; Krista Brucker; Sumedha Gupta
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

9.  Evaluation of drug-drug interactions in hospitalized patients on medications for OUD.

Authors:  Olivia Berger; Katherine Rector; Jacqueline Meredith; Jamielynn Sebaaly
Journal:  Ment Health Clin       Date:  2021-07-16

10.  Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration.

Authors:  Kelsey C Priest; Dennis McCarty; Travis I Lovejoy
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.